| Literature DB >> 23455503 |
Matthew D Neal1, Chhinder P Sodhi, Mitchell Dyer, Brian T Craig, Misty Good, Hongpeng Jia, Ibrahim Yazji, Amin Afrazi, Ward M Richardson, Donna Beer-Stolz, Congrong Ma, Thomas Prindle, Zachary Grant, Maria F Branca, John Ozolek, David J Hackam.
Abstract
Necrotizing enterocolitis (NEC) develops in response to elevated TLR4 signaling in the newborn intestinal epithelium and is characterized by TLR4-mediated inhibition of enterocyte migration and reduced mucosal healing. The downstream processes by which TLR4 impairs mucosal healing remain incompletely understood. In other systems, TLR4 induces autophagy, an adaptive response to cellular stress. We now hypothesize that TLR4 induces autophagy in enterocytes and that TLR4-induced autophagy plays a critical role in NEC development. Using mice selectively lacking TLR4 in enterocytes (TLR4(ΔIEC)) and in TLR4-deficient cultured enterocytes, we now show that TLR4 activation induces autophagy in enterocytes. Immature mouse and human intestine showed increased expression of autophagy genes compared with full-term controls, and NEC development in both mouse and human was associated with increased enterocyte autophagy. Importantly, using mice in which we selectively deleted the autophagy gene ATG7 from the intestinal epithelium (ATG7(ΔIEC)), the induction of autophagy was determined to be required for and not merely a consequence of NEC, because ATG7(ΔIEC) mice were protected from NEC development. In defining the mechanisms involved, TLR4-induced autophagy led to impaired enterocyte migration both in vitro and in vivo, which in cultured enterocytes required the induction of RhoA-mediated stress fibers. These findings depart from current dogma in the field by identifying a unique effect of TLR4-induced autophagy within the intestinal epithelium in the pathogenesis of NEC and identify that the negative consequences of autophagy on enterocyte migration play an essential role in its development.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23455503 PMCID: PMC3608826 DOI: 10.4049/jimmunol.1202264
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422